<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BCL2L12 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>BCL2L12</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9HB09" target="_blank" class="term-link">
                        Q9HB09
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "BCL2L12";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9HB09" data-a="DESCRIPTION: BCL2L12 (Bcl-2-like protein 12) is an atypical ant..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>BCL2L12 (Bcl-2-like protein 12) is an atypical anti-apoptotic member of the Bcl-2 family, characterized by a proline-rich structure with PxxP motifs, a C-terminal BH2 domain, and a BH3-like motif (lacking classical BH1/BH3/BH4 and transmembrane regions). BCL2L12 functions as a dual-site apoptosis inhibitor: in the cytoplasm, it blocks post-mitochondrial apoptosis by directly inhibiting effector caspases (particularly caspase-7, and attenuating caspase-3 activation); in the nucleus, it binds and antagonizes p53 transcriptional activity, preventing induction of p53 target genes (p21, DR5, Noxa, PUMA). BCL2L12 is overexpressed in glioblastoma multiforme (GBM) where it contributes to therapy resistance. GSK3beta phosphorylates BCL2L12 at Ser156, which is required for its anti-apoptotic function. Two major isoforms exist: full-length BCL2L12 (~250 aa) and truncated BCL2L12A (~176 aa, lacking exon 3).</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0005634" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 localizes to both cytoplasm and nucleus. Nuclear localization is functionally important as nuclear BCL2L12 forms complexes with p53 and inhibits p53 transcriptional activity (Stegh &amp; DePinho, 2011; PMID:20837658).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Nuclear localization is well-established and functionally significant. The IBA annotation is consistent with experimental evidence from PMID:20837658 showing nuclear localization in GBM models.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein that is overexpressed in primary GBM</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/BCL2L12/BCL2L12-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">model: Edison Scientific Literature</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902166" target="_blank" class="term-link">
                                    GO:1902166
                                </a>
                            </span>
                            <span class="term-label">negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:1902166" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 inhibits p53-dependent DNA damage-induced apoptosis through direct physical interaction with p53 in the nucleus, attenuating p53 transcriptional activity on target promoters including proapoptotic genes Noxa and PUMA (PMID:20837658).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core function of BCL2L12. The IBA annotation accurately captures the specific role of BCL2L12 in antagonizing p53-mediated intrinsic apoptotic signaling following DNA damage, as demonstrated experimentally.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor, as evidenced by the capacity of Bcl2L12 to...inhibit p53-dependent DNA damage-induced apoptosis...impede the capacity of p53 to bind some of its target gene promoters</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006915" target="_blank" class="term-link">
                                    GO:0006915
                                </a>
                            </span>
                            <span class="term-label">apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0006915" data-r="GO_REF:0000043" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 is a bona fide anti-apoptotic protein with evolved mechanisms for apoptosis inhibition. The generic &#39;apoptotic process&#39; annotation from the UniProt Apoptosis keyword is too vague - the protein specifically negatively regulates apoptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While BCL2L12 is legitimately involved in apoptotic processes as a Bcl-2 family member, this annotation should be more specific. The protein functions as an anti-apoptotic factor through caspase inhibition and p53 antagonism, not as a general participant in apoptosis.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043066" target="_blank" class="term-link">
                                    negative regulation of apoptotic process
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link">
                                        PMID:22262180
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ectopic expression of GFP-fused BCL2L12 or BCL2L12A in U87MG cells leads to repression of apoptotic markers and protects against staurosporine (STS) insults, indicating an antiapoptotic role</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042981" target="_blank" class="term-link">
                                    GO:0042981
                                </a>
                            </span>
                            <span class="term-label">regulation of apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0042981" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 contains a Bcl-2-like superfamily domain (IPR036834) that correctly suggests involvement in apoptosis regulation. This is a valid but general annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IEA annotation from InterPro domain mapping is appropriate as BCL2L12 does regulate apoptosis through its Bcl-2 family membership. More specific annotations (GO:0043066 negative regulation) are present to provide detailed function. This broader term acceptable as general context.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link">
                                        PMID:22262180
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">BCL2L12 has been reported to be involved in post-mitochondrial apoptotic events in glioblastoma</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/29749471" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:29749471
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    GSK3Œ≤‚Äëmediated Ser156 phosphorylation modulates a BH3‚Äëlike d...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0005515" data-r="PMID:29749471" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation captures BCL2L12 interaction with BAX (UniProtKB:Q07812) from the WITH/FROM field. BCL2L12 contains a BH3-like motif that mediates interactions with Bcl-2 family members.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#39;Protein binding&#39; is too vague and uninformative. The specific interaction with BAX should be captured with a more informative term. The BH3-like motif mediates interactions with Bcl-2/Bcl-xL, and BAX interaction is documented in UniProt. A more appropriate annotation would be GO:0051434 (BH3 domain binding) or a specific protein binding term.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051434" target="_blank" class="term-link">
                                    BH3 domain binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/29749471" target="_blank" class="term-link">
                                        PMID:29749471
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">May 11. GSK3Œ≤‚Äëmediated Ser156 phosphorylation modulates a BH3‚Äëlike domain in BCL2L12 during TMZ‚Äëinduced apoptosis and autophagy in glioma cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:33961781
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Dual proteome-scale networks reveal cell-specific remodeling...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0005515" data-r="PMID:33961781" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BioPlex proteome-scale interaction network detected BCL2L12 interaction with BAX (UniProtKB:Q07812). This is a large-scale high-throughput study.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#39;Protein binding&#39; is uninformative. The interaction with BAX is valid but should be annotated with a more specific MF term such as BH3 domain binding, or as part of the biological process annotations. High-throughput data supports but does not add specificity.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051434" target="_blank" class="term-link">
                                    BH3 domain binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                                        PMID:33961781
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">2021 May 6. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        <br>
                        <span class="isoform-badge" title="This annotation was made on a specific isoform">
                            <a href="https://www.uniprot.org/uniprotkb/Q9HB09-1" target="_blank" class="term-link" style="font-size: 0.7rem;">
                                Q9HB09-1
                            </a>
                        </span>
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19376117" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19376117
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquiti...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0005515" data-r="PMID:19376117" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation from PMID:19376117 captures the interaction between BCL2L12 and ubiquitin (UBC, UniProtKB:P0CG48). The study showed BCL2L12 is degraded through the ubiquitin-proteasome system via N-terminal ubiquitination, and HSP70 protects BCL2L12 from this degradation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#39;Protein binding&#39; is uninformative. The interaction with ubiquitin reflects BCL2L12 being a substrate for ubiquitination, not a core molecular function. The HSP70 interaction (which protects BCL2L12 from degradation) is more functionally relevant but also captured by this vague term.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19376117" target="_blank" class="term-link">
                                        PMID:19376117
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">HSP70 was identified to interact with BCL2L12 and BCL2L12A and protected them from ubiquitinations and degradations in mammalian cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002039" target="_blank" class="term-link">
                                    GO:0002039
                                </a>
                            </span>
                            <span class="term-label">p53 binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0002039" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 directly binds p53 in the nucleus, inhibiting p53 transcriptional activity on target gene promoters. This is a core molecular function essential for BCL2L12&#39;s anti-apoptotic activity (PMID:20837658).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> p53 binding is a well-documented core function of BCL2L12. The IEA annotation (transferred from mouse ortholog) is accurate and supported by experimental evidence in human cells showing physical and functional interaction.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043066" target="_blank" class="term-link">
                                    GO:0043066
                                </a>
                            </span>
                            <span class="term-label">negative regulation of apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22262180
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signalin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0043066" data-r="PMID:22262180" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 is a bona fide anti-apoptotic protein. PMID:22262180 demonstrated that ectopic expression of BCL2L12 or BCL2L12A in U87MG glioma cells represses apoptotic markers and protects against staurosporine-induced apoptosis. GSK3beta phosphorylation at Ser156 is required for this anti-apoptotic function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core function of BCL2L12, well-supported by direct experimental evidence. BCL2L12 inhibits apoptosis through dual mechanisms: cytoplasmic effector caspase inhibition and nuclear p53 antagonism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link">
                                        PMID:22262180
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ectopic expression of GFP-fused BCL2L12 or BCL2L12A in U87MG cells leads to repression of apoptotic markers and protects against staurosporine (STS) insults, indicating an antiapoptotic role for both BCL2L12 and BCL2L12A</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19946888" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19946888
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Defining the membrane proteome of NK cells.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0016020" data-r="PMID:19946888" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:19946888 is a high-throughput membrane proteomics study of NK cells that identified 1843 proteins. BCL2L12 detection in membrane fractions is unexpected given that BCL2L12 lacks a transmembrane domain (unlike typical Bcl-2 family members).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> BCL2L12 is atypical among Bcl-2 family members in lacking a transmembrane domain. Its established localization is cytoplasm and nucleus, not membrane. The HDA detection in membrane fractions from a large-scale study likely represents contamination or transient association rather than functional membrane localization. The primary literature consistently describes BCL2L12 as cytoplasmic and nuclear.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19946888" target="_blank" class="term-link">
                                        PMID:19946888
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Defining the membrane proteome of NK cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045944" target="_blank" class="term-link">
                                    GO:0045944
                                </a>
                            </span>
                            <span class="term-label">positive regulation of transcription by RNA polymerase II</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22262180
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signalin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-undecided">
                            UNDECIDED
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0045944" data-r="PMID:22262180" data-act="UNDECIDED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation suggests BCL2L12 positively regulates Pol II transcription. However, the primary literature describes BCL2L12 as inhibiting p53-mediated transcription, which would be negative regulation. The annotation may reflect indirect effects.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The citation PMID:22262180 focuses on BCL2L12&#39;s anti-apoptotic role and GSK3beta regulation, not direct transcriptional regulation. BCL2L12&#39;s known transcriptional role is inhibiting p53 target gene transcription. Without access to the full text showing direct evidence for positive transcriptional regulation, this annotation requires further verification.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">attenuate endogenous p53-directed transcriptomic changes following genotoxic stress</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link">
                                        PMID:22262180
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20837658
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0005634" data-r="PMID:20837658" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:20837658 directly demonstrated nuclear localization of BCL2L12 and established that nuclear BCL2L12 physically interacts with p53 to inhibit its transcriptional activity on target gene promoters.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Direct experimental evidence (IDA) for nuclear localization. Nuclear localization is functionally essential for BCL2L12&#39;s role in p53 antagonism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein that is overexpressed in primary GBM...nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043027" target="_blank" class="term-link">
                                    GO:0043027
                                </a>
                            </span>
                            <span class="term-label">cysteine-type endopeptidase inhibitor activity involved in apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20837658
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0043027" data-r="PMID:20837658" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 directly inhibits effector caspase-7 (and attenuates caspase-3 activation) downstream of mitochondrial permeabilization. This is a core molecular mechanism described in the deep research file (BCL2L12-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The deep research and literature consistently describe BCL2L12 as directly inhibiting effector caspases, particularly caspase-7. This function is not currently annotated but is well-documented in the literature as a core anti-apoptotic mechanism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                        PMID:20837658
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">functions to inhibit post-mitochondrial apoptosis signaling</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051434" target="_blank" class="term-link">
                                    GO:0051434
                                </a>
                            </span>
                            <span class="term-label">BH3 domain binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22262180
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signalin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q9HB09" data-a="GO:0051434" data-r="PMID:22262180" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> BCL2L12 contains a BH3-like motif (residues ~192-220) that mediates binding to anti-apoptotic Bcl-2 family members (Bcl-2, Bcl-xL). Mutations in key residues (L213, L217) restore apoptosis signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The BH3-like motif is a characterized functional domain mediating protein-protein interactions with Bcl-2 family members. This is more informative than generic &#39;protein binding&#39; for capturing BCL2L12&#39;s molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link">
                                        PMID:22262180
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">a BCL2L12(153-191) fragment located outside of the C-terminal BH2 motif is responsible for GSK3b binding</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>BCL2L12 directly inhibits effector caspases (particularly caspase-7) and attenuates caspase-3 activation downstream of mitochondrial permeabilization, acting as a post-mitochondrial block to apoptosis execution (PMID:20837658, BCL2L12-deep-research-falcon.md).</h3>
                <span class="vote-buttons" data-g="Q9HB09" data-a="FUNCTION: BCL2L12 directly inhibits effector caspases (parti..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043027" target="_blank" class="term-link">
                            cysteine-type endopeptidase inhibitor activity involved in apoptotic process
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043066" target="_blank" class="term-link">
                                negative regulation of apoptotic process
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                PMID:20837658
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">functions to inhibit post-mitochondrial apoptosis signaling</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>BCL2L12 binds p53 in the nucleus and antagonizes p53 transcriptional activity, preventing p53 from binding to target gene promoters (p21, Noxa, PUMA, DR5) and attenuating DNA damage-induced apoptosis (PMID:20837658).</h3>
                <span class="vote-buttons" data-g="Q9HB09" data-a="FUNCTION: BCL2L12 binds p53 in the nucleus and antagonizes p..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002039" target="_blank" class="term-link">
                            p53 binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902166" target="_blank" class="term-link">
                                negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                                PMID:20837658
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19376117" target="_blank" class="term-link">
                            PMID:19376117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19946888" target="_blank" class="term-link">
                            PMID:19946888
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Defining the membrane proteome of NK cells.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20837658" target="_blank" class="term-link">
                            PMID:20837658
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22262180" target="_blank" class="term-link">
                            PMID:22262180
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29749471" target="_blank" class="term-link">
                            PMID:29749471
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">GSK3Œ≤‚Äëmediated Ser156 phosphorylation modulates a BH3‚Äëlike domain in BCL2L12 during TMZ‚Äëinduced apoptosis and autophagy in glioma cells.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                            PMID:33961781
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/BCL2L12/BCL2L12-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research report on BCL2L12</div>
                
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(BCL2L12-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9HB09" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2026-01-18T20:18:01.766031'<br />
end_time: '2026-01-18T20:25:04.390861'<br />
duration_seconds: 422.62<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: BCL2L12<br />
  gene_symbol: BCL2L12<br />
  uniprot_accession: Q9HB09<br />
  protein_description: 'RecName: Full=Bcl-2-like protein 12 {ECO:0000305}; Short=Bcl2-L-12;<br />
    AltName: Full=Bcl-2-related proline-rich protein;'<br />
  gene_info: Name=BCL2L12 {ECO:0000312|HGNC:HGNC:13787}; Synonyms=BPR;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the Bcl-2 family. .<br />
  protein_domains: Bcl-2-like_sf. (IPR036834)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 17</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9HB09</li>
<li><strong>Protein Description:</strong> RecName: Full=Bcl-2-like protein 12 {ECO:0000305}; Short=Bcl2-L-12; AltName: Full=Bcl-2-related proline-rich protein;</li>
<li><strong>Gene Information:</strong> Name=BCL2L12 {ECO:0000312|HGNC:HGNC:13787}; Synonyms=BPR;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the Bcl-2 family. .</li>
<li><strong>Key Domains:</strong> Bcl-2-like_sf. (IPR036834)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "BCL2L12" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'BCL2L12' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>BCL2L12</strong> (gene ID: BCL2L12, UniProt: Q9HB09) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9HB09</li>
<li><strong>Protein Description:</strong> RecName: Full=Bcl-2-like protein 12 {ECO:0000305}; Short=Bcl2-L-12; AltName: Full=Bcl-2-related proline-rich protein;</li>
<li><strong>Gene Information:</strong> Name=BCL2L12 {ECO:0000312|HGNC:HGNC:13787}; Synonyms=BPR;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the Bcl-2 family. .</li>
<li><strong>Key Domains:</strong> Bcl-2-like_sf. (IPR036834)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "BCL2L12" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'BCL2L12' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>BCL2L12</strong> (gene ID: BCL2L12, UniProt: Q9HB09) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan and verification summary<br />
- Identity check: The target matches human BCL2L12 (Bcl-2-like protein 12), also known as Bcl2L12, an atypical Bcl-2 family member with proline-rich regions and a C-terminal BH2-like feature; literature places it prominently in human glioblastoma biology, consistent with a Homo sapiens protein (reviewed in glioma context) (kouri2012theroleof pages 4-5, stegh2011beyondeffectorcaspase pages 3-4). Domain reports in primary and review works converge on a proline-rich protein with PxxP motifs, a single C-terminal BH2 domain, and a BH3-like motif‚Äîconsistent with a Bcl-2 family classification (kouri2012theroleof pages 4-5, yang2015bcl2l12witha pages 1-2, yang2015bcl2l12witha pages 12-13).</p>
<p>Comprehensive research report on BCL2L12 (UniProt: Q9HB09)</p>
<p>1) Key concepts and definitions<br />
- Gene/protein and family: BCL2L12 encodes Bcl-2-like protein 12, an atypical Bcl-2 family protein. Unlike canonical prosurvival Bcl-2 proteins, BCL2L12 is proline-rich and is characterized by PxxP motifs and a single C-terminal BH2 domain; it lacks BH1/BH3/BH4 and a transmembrane region, yet carries a BH3-like motif that mediates interactions with antiapoptotic Bcl-2 homologs (Kouri et al., 2012; Yang et al., 2015; URL: https://doi.org/10.1100/2012/838916; https://doi.org/10.3892/ijo.2015.2838) (kouri2012theroleof pages 4-5, yang2015bcl2l12witha pages 1-2).<br />
- Cellular roles: BCL2L12 functions as a dual-site apoptosis regulator. In the cytoplasm, it blocks post-mitochondrial apoptosis signaling by inhibiting effector caspases. In the nucleus, it binds and neutralizes p53 transcriptional activity, limiting the induction of p53 target genes and apoptosis (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).<br />
- Localization: Detected in both cytoplasm and nucleus in glioma models and tissues; nuclear complexes with p53 are functionally important (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).</p>
<p>2) Recent developments and latest research (emphasis on mechanisms and regulatory insights)<br />
Note: Our retrieved, citable corpus is dominated by foundational primary studies and reviews up to 2015. We summarize the current mechanistic understanding below and, where possible, include quantitative results from those sources. More recent 2023‚Äì2024 items relevant to nanotherapy and splicing regulation were identified in searches, but we were unable to retrieve full evidence for direct citation here; therefore, this section reflects earlier, still-current mechanistic studies and explicitly notes the evidence gap for 2023‚Äì2024.<br />
- GSK3Œ≤ regulation and Ser156 phosphorylation: BCL2L12 directly interacts with GSK3Œ≤; GSK3Œ≤ phosphorylates BCL2L12 at Ser156. The S156A mutant loses antiapoptotic function, and LiCl (a GSK3Œ≤ inhibitor) reduces BCL2L12-mediated survival signaling in glioblastoma cells (Chou et al., 2012; URL: https://doi.org/10.4161/cc.11.3.19051) (chou2012gsk3betaregulatesbcl2l12 pages 1-2).<br />
- BH3-like motif function and interaction specificity: A BH3-like segment within BCL2L12 mediates binding to Bcl-2/Bcl-xL; mutating key hydrophobic residues (e.g., L213, L217) restores apoptosis signaling (cleaved PARP, caspase-3 activation, cytochrome c release), supporting a model in which BCL2L12‚Äôs BH3-like region underpins its antiapoptotic interactions (Yang et al., 2015; URL: https://doi.org/10.3892/ijo.2015.2838) (yang2015bcl2l12witha pages 1-2, yang2015bcl2l12witha pages 12-13).<br />
- Post-mitochondrial blockade of apoptosis: BCL2L12 inhibits effector caspases downstream of mitochondrial permeabilization and apoptosome assembly; it binds caspase-7 directly and reduces caspase-3 activation in part via Œ±B-crystallin upregulation (reviewed in Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).<br />
- Nuclear inhibition of p53 tumor suppressor: BCL2L12 forms complexes with p53 in the nucleus, blunting p53‚Äôs transcriptional activation of targets such as p21, DR5, Noxa, and PUMA, and reducing p53 stability. This mechanism suppresses DNA damage‚Äìinduced apoptosis and senescence programs (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 1-3).<br />
- Isoforms and expression in GBM: Two major isoforms are described. Full-length BCL2L12 (~334 aa) and a truncated splice isoform BCL2L12A (~176 aa, lacks exon 3). mRNA overexpression in glioblastoma was reported at approximately 52% for BCL2L12, 76% for BCL2L12A, and 86% for either isoform (Chou et al., 2012; URL: https://doi.org/10.4161/cc.11.3.19051) (chou2012gsk3betaregulatesbcl2l12 pages 1-2).</p>
<p>3) Current applications and real-world implementations<br />
- Biomarker applications in hematologic malignancy: In a qRT-PCR study of 65 CLL patients vs. 23 controls, BCL2L12 mRNA was significantly elevated in CLL, showed strong discriminatory performance in ROC analysis, predicted CLL presence by logistic regression, and high expression associated with advanced clinical stage and shorter overall survival (Papageorgiou et al., 2011; URL: https://doi.org/10.1634/theoncologist.2010-0349) (papageorgiou2011thenovelmember pages 1-2).<br />
- Therapeutic concepts in GBM (preclinical): Mechanistic studies suggest BCL2L12 contributes to chemoradiation resistance by blocking caspase activation and neutralizing p53. Strategies proposed include disrupting BCL2L12‚Äìp53 interactions, inhibiting BCL2L12‚Äôs BH3-like binding surface, and pairing BH3 mimetics (e.g., ABT-737) with temozolomide to overcome resistance (Yang et al., 2015; Stegh &amp; DePinho, 2011; URLs: https://doi.org/10.3892/ijo.2015.2838; https://doi.org/10.4161/cc.10.1.14365) (yang2015bcl2l12witha pages 12-13, stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).</p>
<p>4) Expert opinions and analysis from authoritative sources<br />
- Authoritative reviews emphasize BCL2L12 as an ‚Äúatypical‚Äù Bcl-2 family oncoprotein that operates both in the cytoplasm (effector caspase blockade) and nucleus (p53 antagonism), thereby conferring potent apoptosis resistance and promoting necrotic outcomes in glioblastoma contexts. Elevated expression is frequent in primary GBM by tissue analysis (Stegh &amp; DePinho, 2011; review perspective; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).<br />
- In malignant astrocytic gliomas, BCL2L12 is highlighted as a critical modulator of therapy response with mechanistic placement downstream of mitochondrial permeabilization and upstream of executioner caspase activity and p53-driven transcription, making it a rational target to sensitize GBM to cytotoxic therapies (Kouri et al., 2012; URL: https://doi.org/10.1100/2012/838916) (kouri2012theroleof pages 4-5).</p>
<p>5) Relevant statistics and data from recent studies (from accessible evidence)<br />
- Glioblastoma overexpression: Reviews summarizing tissue microarray data report robust BCL2L12 expression in a high fraction of primary GBM specimens (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4). While the review context indicates very high prevalence, precise numerical breakdowns vary by cohort and method; in parallel, mRNA-level overexpression of splice isoforms was quantified at 52% (BCL2L12), 76% (BCL2L12A), and 86% for either transcript in GBM (Chou et al., 2012; URL: https://doi.org/10.4161/cc.11.3.19051) (chou2012gsk3betaregulatesbcl2l12 pages 1-2).<br />
- CLL cohort: In a clinical cohort of 65 CLL patients, BCL2L12 mRNA was significantly elevated vs. 23 controls; ROC and multivariate models supported diagnostic value, and high BCL2L12 predicted shorter overall survival (Papageorgiou et al., 2011; URL: https://doi.org/10.1634/theoncologist.2010-0349) (papageorgiou2011thenovelmember pages 1-2).</p>
<p>Primary molecular functions and pathway placement (focused synthesis)<br />
- Effector caspase inhibition: BCL2L12 acts downstream of cytochrome c/apoptosome formation to inhibit caspase-7 directly and attenuate caspase-3 activity, effecting a post-mitochondrial block that shifts death outcomes and fosters therapy resistance (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).<br />
- p53 pathway antagonism: Nuclear BCL2L12 complexes with p53, diminishes p53 stability, and prevents p53 binding to target promoters, impairing canonical p53 responses to genotoxic stress (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 1-3).<br />
- BH3-like interactions: The BH3-like motif is required for binding to Bcl-2/Bcl-xL; mutations in the motif restore apoptotic signaling, indicating that this interface is a potential therapeutic target (Yang et al., 2015; URL: https://doi.org/10.3892/ijo.2015.2838) (yang2015bcl2l12witha pages 1-2, yang2015bcl2l12witha pages 12-13).<br />
- Regulation: GSK3Œ≤ binds and phosphorylates BCL2L12 at S156, which is necessary for its antiapoptotic activity; pharmacologic GSK3Œ≤ inhibition (e.g., LiCl) reduces BCL2L12-mediated survival, implicating kinase control as a regulatory node (Chou et al., 2012; URL: https://doi.org/10.4161/cc.11.3.19051) (chou2012gsk3betaregulatesbcl2l12 pages 1-2).<br />
- Isoforms: Full-length BCL2L12 and BCL2L12A (exon 3 skipping) are both expressed; BCL2L12A lacks the S156 site and BH2-containing region, with distinct functional properties and prevalent expression in GBM (Chou et al., 2012; URL: https://doi.org/10.4161/cc.11.3.19051) (chou2012gsk3betaregulatesbcl2l12 pages 1-2).</p>
<p>Cellular localization<br />
- BCL2L12 operates in both the cytoplasm and nucleus. Cytoplasmic activity underlies effector caspase blockade; nuclear activity involves direct interference with p53-mediated transcription (Stegh &amp; DePinho, 2011; URL: https://doi.org/10.4161/cc.10.1.14365) (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3).</p>
<p>Disease associations and translational relevance<br />
- Glioblastoma: High-level BCL2L12 expression is a defining feature of many GBM samples, and functional data place BCL2L12 as a driver of therapy resistance via caspase inhibition and p53 suppression. Targeting BCL2L12 (protein‚Äìprotein interfaces, kinase regulation, RNA interference) is a rational strategy to improve apoptotic responses in GBM (Stegh &amp; DePinho, 2011; Kouri et al., 2012; Yang et al., 2015; URLs: https://doi.org/10.4161/cc.10.1.14365; https://doi.org/10.1100/2012/838916; https://doi.org/10.3892/ijo.2015.2838) (stegh2011beyondeffectorcaspase pages 3-4, kouri2012theroleof pages 4-5, yang2015bcl2l12witha pages 12-13).<br />
- Hematologic malignancy: Elevated BCL2L12 mRNA in CLL correlates with advanced disease and worse survival, supporting its potential as a biomarker (Papageorgiou et al., 2011; URL: https://doi.org/10.1634/theoncologist.2010-0349) (papageorgiou2011thenovelmember pages 1-2).</p>
<p>Embedded evidence summary table<br />
| Topic | Key finding (1‚Äì2 sentences) | Model/context | Source (authors, year) | URL | Pub date (Month Year) | Citation ID |<br />
|---|---|---:|---|---|---:|---|<br />
| Identity &amp; family | BCL2L12 encodes a proline-rich, atypical Bcl-2 family protein (~334 aa) that lacks classical BH1/BH3/BH4 and transmembrane motifs but is implicated in tumorigenesis and therapy resistance. | Human tissues and glioma specimens | Kouri F.M. et al., 2012 | https://doi.org/10.1100/2012/838916 | Feb 2012 | pqac-00000006 |<br />
| Domain architecture | Contains multiple PxxP proline-rich motifs, a single C-terminal BH2 domain and a 12-residue BH3-like motif that mediates interactions with Bcl-2/Bcl-xL. | Sequence/functional mapping; glioma cell assays | Yang M.-C. et al., 2015 | https://doi.org/10.3892/ijo.2015.2838 | Mar 2015 | pqac-00000002 |<br />
| Subcellular localization | Localizes to both cytoplasm and nucleus; nuclear BCL2L12 forms complexes with p53 and cytoplasmic protein mediators to exert anti-apoptotic effects. | GBM cell lines and tissue microarrays | Stegh A.H. &amp; DePinho R.A., 2011 | https://doi.org/10.4161/cc.10.1.14365 | Jan 2011 | pqac-00000000 |<br />
| Primary molecular function ‚Äî effector caspase inhibition | Blocks post-mitochondrial apoptosis by inhibiting effector caspases (directly inhibiting caspase-7 and attenuating caspase-3 activation), producing apoptosis resistance. | Functional assays in glioma models (caspase readouts) | Stegh A.H. et al. (reviewed), 2011 | https://doi.org/10.4161/cc.10.1.14365 | Jan 2011 | pqac-00000000 |<br />
| Primary molecular function ‚Äî p53 modulation | Interacts with and neutralizes p53 transactivation, reducing p53 stability and preventing binding to target promoters (e.g., p21, PUMA, Noxa), thereby attenuating p53-dependent apoptosis. | GBM models; promoter/transactivation assays | Stegh A.H. &amp; DePinho R.A., 2011 | https://doi.org/10.4161/cc.10.1.14365 | Jan 2011 | pqac-00000003 |<br />
| Mechanisms (post-mitochondrial blockade; BH3-like interactions) | Acts downstream of mitochondria to block apoptosome/effector activity; a minimal region (‚âàresidues 192‚Äì220; L213/L217 critical) contains the BH3-like motif required for binding anti-apoptotic Bcl-2 homologs. | Mutational mapping and U87MG glioma assays | Yang M.-C. et al., 2015 | https://doi.org/10.3892/ijo.2015.2838 | Mar 2015 | pqac-00000004 |<br />
| Regulation (GSK3Œ≤ phosphorylation S156; LiCl sensitivity) | GSK3Œ≤ phosphorylates BCL2L12 at Ser156; S156 phosphorylation is required for anti-apoptotic activity and GSK3Œ≤ inhibition (e.g., LiCl) reduces BCL2L12-mediated survival. | Yeast two-hybrid, phosphorylation mutants, GBM cell lines | Chou C.-H. et al., 2012 | https://doi.org/10.4161/cc.11.3.19051 | Feb 2012 | pqac-00000001 |<br />
| Isoforms (BCL2L12 and BCL2L12A) | Two main transcripts: full-length (~334 aa) and truncated BCL2L12A (lacks exon 3, ~176 aa); expression in GBM reported as mRNA overexpression in ~52% (BCL2L12), 76% (BCL2L12A), and 86% for either isoform. | GBM tumor expression profiling | Chou C.-H. et al., 2012 | https://doi.org/10.4161/cc.11.3.19051 | Feb 2012 | pqac-00000001 |<br />
| Pathway placement | Functions at the intersection of intrinsic (mitochondrial) apoptosis and p53 tumor-suppressor signaling, contributing to therapy resistance in glioma models. | Review synthesis and functional studies in glioma | Kouri F.M. et al., 2012 | https://doi.org/10.1100/2012/838916 | Feb 2012 | pqac-00000006 |<br />
| Disease associations / biomarkers | Overexpressed in primary glioblastoma (high frequency in tumor specimens) and elevated BCL2L12 mRNA in CLL (n=65) associates with advanced stage and shorter overall survival (qRT‚ÄëPCR study). | GBM tissue analyses; CLL patient cohort (65 patients vs 23 controls) | Stegh A.H. review 2011; Papageorgiou S.G. et al., 2011 | https://doi.org/10.4161/cc.10.1.14365 ; https://doi.org/10.1634/theoncologist.2010-0349 | Jan 2011 ; Sep 2011 | pqac-00000003, pqac-00000005 |</p>
<p><em>Table: Compact table summarizing key molecular features, mechanisms, regulation, isoforms, pathway placement, and disease associations for human BCL2L12 (UniProt Q9HB09) with primary literature links and context IDs for traceability.</em></p>
<p>Gaps and limitations<br />
- Despite targeted searches, we could not retrieve citable 2023‚Äì2024 full-text evidence within the current tool context. Consequently, the latest translational advances (e.g., nanotechnology-enabled delivery targeting BCL2L12, splicing-factor modulation of BCL2L12, or newer clinical datasets) are not detailed here. The mechanistic conclusions above are grounded in earlier, peer-reviewed human studies that remain widely cited. We recommend updating with 2023‚Äì2024 sources as they become accessible to confirm whether newer clinical cohorts or therapeutic platforms (e.g., BH3 mimetics, kinase modulators, nucleic acid therapeutics) have produced validated efficacy/signature data specific to BCL2L12 in GBM or other cancers (stegh2011beyondeffectorcaspase pages 3-4, chou2012gsk3betaregulatesbcl2l12 pages 1-2, yang2015bcl2l12witha pages 1-2, stegh2011beyondeffectorcaspase pages 1-3, yang2015bcl2l12witha pages 12-13, papageorgiou2011thenovelmember pages 1-2, kouri2012theroleof pages 4-5, yang2015bcl2l12witha pages 13-13).</p>
<p>References (URLs and publication dates)<br />
- Stegh A.H. &amp; DePinho R.A. Beyond effector caspase inhibition. Cell Cycle. Jan 2011. URL: https://doi.org/10.4161/cc.10.1.14365 (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3)<br />
- Chou C.-H. et al. GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl. The FASEB Journal/Cell Cycle report. Feb 2012. URL: https://doi.org/10.4161/cc.11.3.19051 (chou2012gsk3betaregulatesbcl2l12 pages 1-2)<br />
- Yang M.-C. et al. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy. Int J Oncol. Mar 2015. URL: https://doi.org/10.3892/ijo.2015.2838 (yang2015bcl2l12witha pages 1-2, yang2015bcl2l12witha pages 12-13)<br />
- Kouri F.M., Jensen S.A., Stegh A.H. The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond. The Scientific World Journal. Feb 2012. URL: https://doi.org/10.1100/2012/838916 (kouri2012theroleof pages 4-5)<br />
- Papageorgiou S.G. et al. BCL2L12 elevated in CLL: biomarker value. The Oncologist. Sep 2011. URL: https://doi.org/10.1634/theoncologist.2010-0349 (papageorgiou2011thenovelmember pages 1-2)</p>
<p>Citations<br />
- Identity, localization, dual mechanism (caspases and p53): (stegh2011beyondeffectorcaspase pages 3-4, stegh2011beyondeffectorcaspase pages 1-3)<br />
- Domain architecture, BH3-like motif function: (kouri2012theroleof pages 4-5, yang2015bcl2l12witha pages 1-2, yang2015bcl2l12witha pages 12-13)<br />
- Regulation (GSK3Œ≤, S156; LiCl sensitivity): (chou2012gsk3betaregulatesbcl2l12 pages 1-2)<br />
- Isoforms and GBM expression percentages: (chou2012gsk3betaregulatesbcl2l12 pages 1-2)<br />
- Biomarker in CLL with cohort statistics: (papageorgiou2011thenovelmember pages 1-2)</p>
<p>References</p>
<ol>
<li>
<p>(kouri2012theroleof pages 4-5): Fotini M. Kouri, Samuel A. Jensen, and Alexander H. Stegh. The role of bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: bcl2l12 and beyond. The Scientific World Journal, 2012:1-8, Feb 2012. URL: https://doi.org/10.1100/2012/838916, doi:10.1100/2012/838916. This article has 65 citations.</p>
</li>
<li>
<p>(stegh2011beyondeffectorcaspase pages 3-4): Alexander H. Stegh and Ronald A. DePinho. Beyond effector caspase inhibition. Cell Cycle, 10:33-38, Jan 2011. URL: https://doi.org/10.4161/cc.10.1.14365, doi:10.4161/cc.10.1.14365. This article has 90 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(yang2015bcl2l12witha pages 1-2): MING-CHANG YANG, JOON-KHIM LOH, YI-YANG LI, WEN-SHENG HUANG, CHIA-HUA CHOU, JIIN-TSUEY CHENG, YENG-TSENG WANG, ANN-SHUNG LIEU, SHEN-LONG HOWNG, YI-REN HONG, and AN-KUO CHOU. Bcl2l12 with a bh3-like domain in regulating apoptosis and tmz-induced autophagy: a prospective combination of abt-737 and tmz for treating glioma. International journal of oncology, 46 3:1304-16, Mar 2015. URL: https://doi.org/10.3892/ijo.2015.2838, doi:10.3892/ijo.2015.2838. This article has 35 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(yang2015bcl2l12witha pages 12-13): MING-CHANG YANG, JOON-KHIM LOH, YI-YANG LI, WEN-SHENG HUANG, CHIA-HUA CHOU, JIIN-TSUEY CHENG, YENG-TSENG WANG, ANN-SHUNG LIEU, SHEN-LONG HOWNG, YI-REN HONG, and AN-KUO CHOU. Bcl2l12 with a bh3-like domain in regulating apoptosis and tmz-induced autophagy: a prospective combination of abt-737 and tmz for treating glioma. International journal of oncology, 46 3:1304-16, Mar 2015. URL: https://doi.org/10.3892/ijo.2015.2838, doi:10.3892/ijo.2015.2838. This article has 35 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(stegh2011beyondeffectorcaspase pages 1-3): Alexander H. Stegh and Ronald A. DePinho. Beyond effector caspase inhibition. Cell Cycle, 10:33-38, Jan 2011. URL: https://doi.org/10.4161/cc.10.1.14365, doi:10.4161/cc.10.1.14365. This article has 90 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(chou2012gsk3betaregulatesbcl2l12 pages 1-2): Chia-Hua Chou, An-Kuo Chou, Ching-Chih Lin, Wei-Jay Chen, Chih-Chang Wei, Ming-Chang Yang, Ching-Mei Hsu, For-Wey Lung, Joon-Khim Loh, Shen-Long Howng, and Yi-Ren Hong. Gsk3beta regulates bcl2l12 and bcl2l12a anti‚Äêapoptosis signaling in glioblastoma and is inhibited by licl. The FASEB Journal, 26:532-542, Feb 2012. URL: https://doi.org/10.4161/cc.11.3.19051, doi:10.4161/cc.11.3.19051. This article has 43 citations.</p>
</li>
<li>
<p>(papageorgiou2011thenovelmember pages 1-2): Sotirios G. Papageorgiou, Christos K. Kontos, Vassiliki Pappa, Hellinida Thomadaki, Frida Kontsioti, John Dervenoulas, Efstathios Papageorgiou, Theofanis Economopoulos, and Andreas Scorilas. The novel member of the bcl2 gene family, bcl2l12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. The oncologist, 16 9:1280-91, Sep 2011. URL: https://doi.org/10.1634/theoncologist.2010-0349, doi:10.1634/theoncologist.2010-0349. This article has 44 citations.</p>
</li>
<li>
<p>(yang2015bcl2l12witha pages 13-13): MING-CHANG YANG, JOON-KHIM LOH, YI-YANG LI, WEN-SHENG HUANG, CHIA-HUA CHOU, JIIN-TSUEY CHENG, YENG-TSENG WANG, ANN-SHUNG LIEU, SHEN-LONG HOWNG, YI-REN HONG, and AN-KUO CHOU. Bcl2l12 with a bh3-like domain in regulating apoptosis and tmz-induced autophagy: a prospective combination of abt-737 and tmz for treating glioma. International journal of oncology, 46 3:1304-16, Mar 2015. URL: https://doi.org/10.3892/ijo.2015.2838, doi:10.3892/ijo.2015.2838. This article has 35 citations and is from a peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>stegh2011beyondeffectorcaspase pages 1-3</li>
<li>papageorgiou2011thenovelmember pages 1-2</li>
<li>kouri2012theroleof pages 4-5</li>
<li>stegh2011beyondeffectorcaspase pages 3-4</li>
<li>https://doi.org/10.1100/2012/838916;</li>
<li>https://doi.org/10.3892/ijo.2015.2838</li>
<li>https://doi.org/10.4161/cc.10.1.14365</li>
<li>https://doi.org/10.4161/cc.11.3.19051</li>
<li>https://doi.org/10.1634/theoncologist.2010-0349</li>
<li>https://doi.org/10.3892/ijo.2015.2838;</li>
<li>https://doi.org/10.1100/2012/838916</li>
<li>https://doi.org/10.4161/cc.10.1.14365;</li>
<li>https://doi.org/10.1100/2012/838916,</li>
<li>https://doi.org/10.4161/cc.10.1.14365,</li>
<li>https://doi.org/10.3892/ijo.2015.2838,</li>
<li>https://doi.org/10.4161/cc.11.3.19051,</li>
<li>https://doi.org/10.1634/theoncologist.2010-0349,</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9HB09
gene_symbol: BCL2L12
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  BCL2L12 (Bcl-2-like protein 12) is an atypical anti-apoptotic member of the Bcl-2
  family,
  characterized by a proline-rich structure with PxxP motifs, a C-terminal BH2 domain,
  and
  a BH3-like motif (lacking classical BH1/BH3/BH4 and transmembrane regions). BCL2L12
  functions as a dual-site apoptosis inhibitor: in the cytoplasm, it blocks post-mitochondrial
  apoptosis by directly inhibiting effector caspases (particularly caspase-7, and
  attenuating
  caspase-3 activation); in the nucleus, it binds and antagonizes p53 transcriptional
  activity,
  preventing induction of p53 target genes (p21, DR5, Noxa, PUMA). BCL2L12 is overexpressed
  in glioblastoma multiforme (GBM) where it contributes to therapy resistance. GSK3beta
  phosphorylates BCL2L12 at Ser156, which is required for its anti-apoptotic function.
  Two major isoforms exist: full-length BCL2L12 (~250 aa) and truncated BCL2L12A (~176
  aa,
  lacking exon 3).
existing_annotations:
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        BCL2L12 localizes to both cytoplasm and nucleus. Nuclear localization is functionally
        important as nuclear BCL2L12 forms complexes with p53 and inhibits p53 transcriptional
        activity (Stegh &amp; DePinho, 2011; PMID:20837658).
      action: ACCEPT
      reason: &gt;-
        Nuclear localization is well-established and functionally significant. The
        IBA annotation
        is consistent with experimental evidence from PMID:20837658 showing nuclear
        localization
        in GBM models.
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear
            protein that is overexpressed in primary GBM&#34;
        - reference_id: file:human/BCL2L12/BCL2L12-deep-research-falcon.md
          supporting_text: &#39;model: Edison Scientific Literature&#39;
  - term:
      id: GO:1902166
      label: negative regulation of intrinsic apoptotic signaling pathway in 
        response to DNA damage by p53 class mediator
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        BCL2L12 inhibits p53-dependent DNA damage-induced apoptosis through direct
        physical
        interaction with p53 in the nucleus, attenuating p53 transcriptional activity
        on
        target promoters including proapoptotic genes Noxa and PUMA (PMID:20837658).
      action: ACCEPT
      reason: &gt;-
        This is a core function of BCL2L12. The IBA annotation accurately captures
        the specific
        role of BCL2L12 in antagonizing p53-mediated intrinsic apoptotic signaling
        following
        DNA damage, as demonstrated experimentally.
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;nuclear Bcl2L12 physically and functionally interacts
            with the p53 tumor suppressor, as evidenced by the capacity of Bcl2L12
            to...inhibit p53-dependent DNA damage-induced apoptosis...impede the capacity
            of p53 to bind some of its target gene promoters&#34;
  - term:
      id: GO:0006915
      label: apoptotic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: &gt;-
        BCL2L12 is a bona fide anti-apoptotic protein with evolved mechanisms for
        apoptosis
        inhibition. The generic &#39;apoptotic process&#39; annotation from the UniProt Apoptosis
        keyword is too vague - the protein specifically negatively regulates apoptosis.
      action: MODIFY
      reason: &gt;-
        While BCL2L12 is legitimately involved in apoptotic processes as a Bcl-2 family
        member,
        this annotation should be more specific. The protein functions as an anti-apoptotic
        factor through caspase inhibition and p53 antagonism, not as a general participant
        in apoptosis.
      proposed_replacement_terms:
        - id: GO:0043066
          label: negative regulation of apoptotic process
      supported_by:
        - reference_id: PMID:22262180
          supporting_text: &#34;Ectopic expression of GFP-fused BCL2L12 or BCL2L12A in
            U87MG cells leads to repression of apoptotic markers and protects against
            staurosporine (STS) insults, indicating an antiapoptotic role&#34;
  - term:
      id: GO:0042981
      label: regulation of apoptotic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: &gt;-
        BCL2L12 contains a Bcl-2-like superfamily domain (IPR036834) that correctly
        suggests
        involvement in apoptosis regulation. This is a valid but general annotation.
      action: ACCEPT
      reason: &gt;-
        The IEA annotation from InterPro domain mapping is appropriate as BCL2L12
        does regulate
        apoptosis through its Bcl-2 family membership. More specific annotations (GO:0043066
        negative regulation) are present to provide detailed function. This broader
        term
        acceptable as general context.
      supported_by:
        - reference_id: PMID:22262180
          supporting_text: &#34;BCL2L12 has been reported to be involved in post-mitochondrial
            apoptotic events in glioblastoma&#34;
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29749471
    review:
      summary: &gt;-
        This annotation captures BCL2L12 interaction with BAX (UniProtKB:Q07812) from
        the
        WITH/FROM field. BCL2L12 contains a BH3-like motif that mediates interactions
        with
        Bcl-2 family members.
      action: REMOVE
      reason: &gt;-
        &#39;Protein binding&#39; is too vague and uninformative. The specific interaction
        with BAX
        should be captured with a more informative term. The BH3-like motif mediates
        interactions with Bcl-2/Bcl-xL, and BAX interaction is documented in UniProt.
        A more
        appropriate annotation would be GO:0051434 (BH3 domain binding) or a specific
        protein binding term.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:29749471
          supporting_text: May 11. GSK3Œ≤‚Äëmediated Ser156 phosphorylation 
            modulates a BH3‚Äëlike domain in BCL2L12 during TMZ‚Äëinduced apoptosis 
            and autophagy in glioma cells.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:33961781
    review:
      summary: &gt;-
        BioPlex proteome-scale interaction network detected BCL2L12 interaction with
        BAX
        (UniProtKB:Q07812). This is a large-scale high-throughput study.
      action: REMOVE
      reason: &gt;-
        &#39;Protein binding&#39; is uninformative. The interaction with BAX is valid but
        should be
        annotated with a more specific MF term such as BH3 domain binding, or as part
        of
        the biological process annotations. High-throughput data supports but does
        not add
        specificity.
      proposed_replacement_terms:
        - id: GO:0051434
          label: BH3 domain binding
      supported_by:
        - reference_id: PMID:33961781
          supporting_text: 2021 May 6. Dual proteome-scale networks reveal 
            cell-specific remodeling of the human interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19376117
    review:
      summary: &gt;-
        This annotation from PMID:19376117 captures the interaction between BCL2L12
        and
        ubiquitin (UBC, UniProtKB:P0CG48). The study showed BCL2L12 is degraded through
        the ubiquitin-proteasome system via N-terminal ubiquitination, and HSP70 protects
        BCL2L12 from this degradation.
      action: REMOVE
      reason: &gt;-
        &#39;Protein binding&#39; is uninformative. The interaction with ubiquitin reflects
        BCL2L12
        being a substrate for ubiquitination, not a core molecular function. The HSP70
        interaction (which protects BCL2L12 from degradation) is more functionally
        relevant
        but also captured by this vague term.
      supported_by:
        - reference_id: PMID:19376117
          supporting_text: &#34;HSP70 was identified to interact with BCL2L12 and BCL2L12A
            and protected them from ubiquitinations and degradations in mammalian
            cells&#34;
    isoform: Q9HB09-1
  - term:
      id: GO:0002039
      label: p53 binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: &gt;-
        BCL2L12 directly binds p53 in the nucleus, inhibiting p53 transcriptional
        activity
        on target gene promoters. This is a core molecular function essential for
        BCL2L12&#39;s
        anti-apoptotic activity (PMID:20837658).
      action: ACCEPT
      reason: &gt;-
        p53 binding is a well-documented core function of BCL2L12. The IEA annotation
        (transferred from mouse ortholog) is accurate and supported by experimental
        evidence
        in human cells showing physical and functional interaction.
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;nuclear Bcl2L12 physically and functionally interacts
            with the p53 tumor suppressor&#34;
  - term:
      id: GO:0043066
      label: negative regulation of apoptotic process
    evidence_type: IDA
    original_reference_id: PMID:22262180
    review:
      summary: &gt;-
        BCL2L12 is a bona fide anti-apoptotic protein. PMID:22262180 demonstrated
        that
        ectopic expression of BCL2L12 or BCL2L12A in U87MG glioma cells represses
        apoptotic
        markers and protects against staurosporine-induced apoptosis. GSK3beta phosphorylation
        at Ser156 is required for this anti-apoptotic function.
      action: ACCEPT
      reason: &gt;-
        This is a core function of BCL2L12, well-supported by direct experimental
        evidence.
        BCL2L12 inhibits apoptosis through dual mechanisms: cytoplasmic effector caspase
        inhibition and nuclear p53 antagonism.
      supported_by:
        - reference_id: PMID:22262180
          supporting_text: &#34;Ectopic expression of GFP-fused BCL2L12 or BCL2L12A in
            U87MG cells leads to repression of apoptotic markers and protects against
            staurosporine (STS) insults, indicating an antiapoptotic role for both
            BCL2L12 and BCL2L12A&#34;
  - term:
      id: GO:0016020
      label: membrane
    evidence_type: HDA
    original_reference_id: PMID:19946888
    review:
      summary: &gt;-
        PMID:19946888 is a high-throughput membrane proteomics study of NK cells that
        identified 1843 proteins. BCL2L12 detection in membrane fractions is unexpected
        given that BCL2L12 lacks a transmembrane domain (unlike typical Bcl-2 family
        members).
      action: MARK_AS_OVER_ANNOTATED
      reason: &gt;-
        BCL2L12 is atypical among Bcl-2 family members in lacking a transmembrane
        domain.
        Its established localization is cytoplasm and nucleus, not membrane. The HDA
        detection
        in membrane fractions from a large-scale study likely represents contamination
        or
        transient association rather than functional membrane localization. The primary
        literature consistently describes BCL2L12 as cytoplasmic and nuclear.
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear
            protein&#34;
        - reference_id: PMID:19946888
          supporting_text: Defining the membrane proteome of NK cells.
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IDA
    original_reference_id: PMID:22262180
    review:
      summary: &gt;-
        This annotation suggests BCL2L12 positively regulates Pol II transcription.
        However,
        the primary literature describes BCL2L12 as inhibiting p53-mediated transcription,
        which would be negative regulation. The annotation may reflect indirect effects.
      action: UNDECIDED
      reason: &gt;-
        The citation PMID:22262180 focuses on BCL2L12&#39;s anti-apoptotic role and GSK3beta
        regulation, not direct transcriptional regulation. BCL2L12&#39;s known transcriptional
        role is inhibiting p53 target gene transcription. Without access to the full
        text
        showing direct evidence for positive transcriptional regulation, this annotation
        requires further verification.
      additional_reference_ids:
        - PMID:20837658
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;attenuate endogenous p53-directed transcriptomic changes
            following genotoxic stress&#34;
        - reference_id: PMID:22262180
          supporting_text: GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis 
            signaling in glioblastoma and is inhibited by LiCl.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:20837658
    review:
      summary: &gt;-
        PMID:20837658 directly demonstrated nuclear localization of BCL2L12 and established
        that nuclear BCL2L12 physically interacts with p53 to inhibit its transcriptional
        activity on target gene promoters.
      action: ACCEPT
      reason: &gt;-
        Direct experimental evidence (IDA) for nuclear localization. Nuclear localization
        is functionally essential for BCL2L12&#39;s role in p53 antagonism.
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear
            protein that is overexpressed in primary GBM...nuclear Bcl2L12 physically
            and functionally interacts with the p53 tumor suppressor&#34;
# New annotations suggested based on literature evidence
  - term:
      id: GO:0043027
      label: cysteine-type endopeptidase inhibitor activity involved in 
        apoptotic process
    evidence_type: TAS
    original_reference_id: PMID:20837658
    review:
      summary: &gt;-
        BCL2L12 directly inhibits effector caspase-7 (and attenuates caspase-3 activation)
        downstream of mitochondrial permeabilization. This is a core molecular mechanism
        described in the deep research file (BCL2L12-deep-research-falcon.md).
      action: NEW
      reason: &gt;-
        The deep research and literature consistently describe BCL2L12 as directly
        inhibiting
        effector caspases, particularly caspase-7. This function is not currently
        annotated
        but is well-documented in the literature as a core anti-apoptotic mechanism.
      supported_by:
        - reference_id: PMID:20837658
          supporting_text: &#34;functions to inhibit post-mitochondrial apoptosis signaling&#34;
  - term:
      id: GO:0051434
      label: BH3 domain binding
    evidence_type: TAS
    original_reference_id: PMID:22262180
    review:
      summary: &gt;-
        BCL2L12 contains a BH3-like motif (residues ~192-220) that mediates binding
        to
        anti-apoptotic Bcl-2 family members (Bcl-2, Bcl-xL). Mutations in key residues
        (L213, L217) restore apoptosis signaling.
      action: NEW
      reason: &gt;-
        The BH3-like motif is a characterized functional domain mediating protein-protein
        interactions with Bcl-2 family members. This is more informative than generic
        &#39;protein binding&#39; for capturing BCL2L12&#39;s molecular function.
      supported_by:
        - reference_id: PMID:22262180
          supporting_text: &#34;a BCL2L12(153-191) fragment located outside of the C-terminal
            BH2 motif is responsible for GSK3b binding&#34;
core_functions:
  - description: &gt;-
      BCL2L12 directly inhibits effector caspases (particularly caspase-7) and attenuates
      caspase-3 activation downstream of mitochondrial permeabilization, acting as
      a
      post-mitochondrial block to apoptosis execution (PMID:20837658, BCL2L12-deep-research-falcon.md).
    molecular_function:
      id: GO:0043027
      label: cysteine-type endopeptidase inhibitor activity involved in 
        apoptotic process
    directly_involved_in:
      - id: GO:0043066
        label: negative regulation of apoptotic process
    supported_by:
      - reference_id: PMID:20837658
        supporting_text: &#34;functions to inhibit post-mitochondrial apoptosis signaling&#34;
  - description: &gt;-
      BCL2L12 binds p53 in the nucleus and antagonizes p53 transcriptional activity,
      preventing p53 from binding to target gene promoters (p21, Noxa, PUMA, DR5)
      and
      attenuating DNA damage-induced apoptosis (PMID:20837658).
    molecular_function:
      id: GO:0002039
      label: p53 binding
    directly_involved_in:
      - id: GO:1902166
        label: negative regulation of intrinsic apoptotic signaling pathway in 
          response to DNA damage by p53 class mediator
    locations:
      - id: GO:0005634
        label: nucleus
    supported_by:
      - reference_id: PMID:20837658
        supporting_text: &#34;nuclear Bcl2L12 physically and functionally interacts with
          the p53 tumor suppressor&#34;
references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation 
      data to orthologs using Ensembl Compara
    findings: []
  - id: PMID:19376117
    title: HSP70 protects BCL2L12 and BCL2L12A from N-terminal 
      ubiquitination-mediated proteasomal degradation.
    findings: []
  - id: PMID:19946888
    title: Defining the membrane proteome of NK cells.
    findings: []
  - id: PMID:20837658
    title: Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.
    findings: []
  - id: PMID:22262180
    title: GSK3Œ≤ regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in 
      glioblastoma and is inhibited by LiCl.
    findings: []
  - id: PMID:29749471
    title: GSK3Œ≤‚Äëmediated Ser156 phosphorylation modulates a BH3‚Äëlike domain in 
      BCL2L12 during TMZ‚Äëinduced apoptosis and autophagy in glioma cells.
    findings: []
  - id: PMID:33961781
    title: Dual proteome-scale networks reveal cell-specific remodeling of the 
      human interactome.
    findings: []
  - id: file:human/BCL2L12/BCL2L12-deep-research-falcon.md
    title: Deep research report on BCL2L12
    findings: []
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>